T Lymphoblastic Lymphoma

specific

A type of non-Hodgkin lymphoma in which too many T-cell lymphoblasts (immature white blood cells) are found in the lymph nodes and spleen. It is most common in young men.

55

Centers

25

Active Trials

Cancer Funding

Top Centers for T Lymphoblastic Lymphoma(55)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
63.2
2
NCI Comprehensive
Active Research Program
63.2
3
NCI Comprehensive
Active Research Program
63.2
4
NCI Comprehensive
Active Research Program
63.2
5
NCI Comprehensive
Active Research Program
63.2
663.2
7
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
63.2
8
NCI Comprehensive
Active Research Program
63.2
9
NCI Comprehensive
Active Research Program
63.2
10
NCI Comprehensive
Active Research Program
63.2
11
NCI Comprehensive
Active Research Program
63.2
12
NCI Comprehensive
Active Research Program
63.2
13
NCI Comprehensive
Active Research Program
63.2
14
NCI Comprehensive
Active Research Program
63.2
15
Active Research Program
63.2
16
NCI Clinical
Active Research Program
63.2
17
NCI Comprehensive
Active Research Program
63.2
18
Active Research Program
63.2
19
NCI Comprehensive
Active Research Program
63.2
20
NCI Comprehensive
Active Research Program
63.2
21
Active Research Program
63.2
22
Active Research Program
63.2
23
Active Research Program
63.2
24
Active Research Program
63.2
25
Active Research Program
63.2
26
NCI Comprehensive
40.7
27
NCI Comprehensive
40.7
28
NCI Comprehensive
40.7
29
NCI Comprehensive
40.7
30
NCI Comprehensive
40.7
3140.7
3240.7
3340.7
3440.7
3540.7
3640.7
37
Cedars-Sinai CancerLos Angeles, CA
40.7
3840.7
39
NCI Comprehensive
40.7
40
NCI Comprehensive
40.7
41
NCI Comprehensive
40.7
42
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
40.7
4340.7
4440.7
4540.7
4640.7
4740.7
4840.7
4940.7
5040.7
5140.7
5240.7
5340.7
54
BC CancerVancouver, BC
40.7
5540.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →